Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

785
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
785
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

294
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
294
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

667
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
667
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

375
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
375
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

265
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
265

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of intensive care unit requirement and in-hospital mortality in Fournier's gangrene: a comparative analysis of conventional statistical and machine learning models.

Updates in surgery·2026
Same author

Comment on: Meeting the growing demand: an operational blueprint for a 1500-case-per-year penile implant center of excellence.

International journal of impotence research·2026
Same author

Sexual and urinary outcomes of minimally invasive surgical therapies for LUTS/BPH: a narrative review.

International journal of impotence research·2026
Same author

Patient-reported penile sensory loss, not surgical approach, is associated with sexual satisfaction after inflatable penile prosthesis implantation.

The journal of sexual medicine·2026
Same author

A rare complication following excision and primary anastomosis urethroplasty: Osteomyelitis: a case report.

Medicine·2026
Same author

Impact of operating room personnel density on aerobiome-related infection risk in penile implant surgery.

The journal of sexual medicine·2026
Same journal

The association between age and mortality in men with adult-onset testosterone deficiency is altered by testosterone therapy.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
Same journal

Associations of metabolic heterogeneity of obesity with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): longitudinal cohort and cross-sectional study.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
Same journal

Ubiquitination-anchored signature defines neuroendocrine prostate cancer: hub genes and single-cell ecosystem insights from integrated bioinformatics analysis of public transcriptomic datasets.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
Same journal

SPISE index and ensemble machine learning refine cardiovascular risk stratification in stage 0-3 CKM syndrome.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
Same journal

Relationship between Chinese visceral adiposity index and bone mineral density in patients with type 2 diabetes mellitus.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
Same journal

Testosterone deficiency in aging males: a dual threat to vascular and bone health through coronary artery calcification and osteoporosis - a narrative review.

The aging male : the official journal of the International Society for the Study of the Aging Male·2026
See all related articles

Related Experiment Video

Updated: Dec 24, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

678

The correlation between atherogenic indexes and erectile dysfunction.

Mehmet Gokhan Culha1, Lutfi Canat1, Recep Burak Degirmentepe1

  • 1Department of Urology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey.

The Aging Male : the Official Journal of the International Society for the Study of the Aging Male
|April 9, 2020
PubMed
Summary
This summary is machine-generated.

Higher levels of Castelli

Keywords:
AtherosclerosisCastelli’s risk indexatherogenic indexerectile dysfunction

More Related Videos

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.3K
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

44.3K

Related Experiment Videos

Last Updated: Dec 24, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

678
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.3K
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

44.3K

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Lipid Metabolism

Background:

  • Cardiovascular disease (CVD) risk is often assessed using standard lipid profiles.
  • Novel lipid ratios like Atherogenic Index of Plasma (AIP), Castelli's Risk Index (CRI-1, CRI-2), and Atherogenic Coefficient (AC) offer advanced risk evaluation.
  • Erectile Dysfunction (ED) is increasingly recognized as a potential indicator of underlying vascular health issues.

Purpose of the Study:

  • To investigate the association between AIP, AC, and CRI-1/2 and the severity of vasculogenic erectile dysfunction (ED).
  • To determine if specific lipid ratios can predict the risk or severity of ED in patients.

Main Methods:

  • A cohort of 253 male patients diagnosed with vasculogenic ED was studied.
  • Patients were categorized into mild-to-moderate ED (n=134) and severe ED (n=119) groups.
  • Calculated lipid parameters included CRI-1 (Total Cholesterol/HDL), CRI-2 (LDL/HDL), AIP (log10(Triglycerides/HDL)), and AC (non-HDL/HDL).

Main Results:

  • Patients with severe ED exhibited significantly higher mean values for CRI-1 and AIP compared to those with mild ED.
  • CRI-1 was 4.88 ± 1.30 in severe ED vs. 4.50 ± 1.47 in mild ED (p=0.039).
  • AIP was 0.617 ± 0.283 in severe ED vs. 0.489 ± 0.315 in mild ED (p=0.007).

Conclusions:

  • CRI-1 and AIP demonstrate a positive correlation with the severity of erectile dysfunction.
  • Elevated CRI-1 and AIP levels may indicate a higher likelihood of developing more severe ED in the future.
  • These lipid ratios can serve as valuable biomarkers for assessing vascular health and ED risk.